ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

NIH Investigating Cohn Records Leak

August 15, 1986

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003